Playback speed
10 seconds
Immunotherapy in Stage III NSCLC: Practice-Changing Results of PACIFIC Trial
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
0 views
November 2, 2018
Dr. Jack West reviews data from ESMO 2017 & the NEJM paper on the PACIFIC ...
read more ↘ trial of durvalumab vs. placebo as consolidation after chemoradiation for patients with unresectable stage III NSCLC, focusing especially on why these results are practice-changing.
↖ read less
read more ↘ trial of durvalumab vs. placebo as consolidation after chemoradiation for patients with unresectable stage III NSCLC, focusing especially on why these results are practice-changing.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Lung